We developed pH-responsive liposomes containing synthetic glutamic acid-based
zwitterionic lipids and evaluated their properties both in vitro and in vivo with the aim of …

Strategies used to enhance liposome-mediated drug delivery in vivo include the
enhancement of stability and circulation time in the bloodstream, targeting to specific tissues …

We have reported that targeted, pH-sensitive sterically stabilized liposomes are able to
increase the cytotoxicity of DXR in vitro against B lymphoma cells, but the rate of release of …

Since the discovery of liposomes or lipid vesicles derived from self‐forming enclosed lipid
bilayers upon hydration, liposome drug delivery systems have played a significant role in …

The liposome, a closed phospholipid bilayered vesicular system, has received considerable
attention as a pharmaceutical carrier of great potential over the past 30 years. The ability of …

Liposomes have been used widely to improve the therapeutic activity of pharmaceutical
agents. The traditional approach for such applications has been to formulate the …

Cationic liposomes exhibit a propensity to selectively target tumor-associated blood vessels
demonstrating potential value as anti-cancer drug delivery vehicles. Their utility however, is …

The purpose of this review is to provide an insight into the different aspects of pH‐sensitive
liposomes. The review consists of 6 parts: the first introduces different types of medications …

Endosomal degradation of the nanoparticle is one of the major biological barriers
associated with the drug delivery system. Nanoparticles are internalized in the cell via …

Abstract pH-sensitive liposomes are designed to specifically triggered release the loaded
drugs in response to the change of pH in the surrounding serum. So pH-sensitive liposomes …